Chris Cargill
Vorstandsvorsitzender bei NXERA PHARMA CO., LTD.
Aktive Positionen von Chris Cargill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NXERA PHARMA CO., LTD. | Direktor/Vorstandsmitglied | 24.03.2022 | - |
| Vorstandsvorsitzender | 24.03.2022 | - | |
| Präsident | 24.03.2022 | - | |
| Finanzdirektor/CFO | 01.06.2018 | 24.03.2022 | |
| Investor Relations Kontakt | 01.06.2018 | 24.03.2022 | |
| Public Communications Contact | 20.09.2017 | 01.06.2018 | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Direktor/Vorstandsmitglied | 01.06.2018 | - |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Karriereverlauf von Chris Cargill
Ausbildung von Chris Cargill
| Monash University | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Japan | 2 |
| Australien | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NXERA PHARMA CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Health Technology |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Chris Cargill
- Erfahrung
